摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

β-(3,4-dihydroxyphenyl)propionamide | 1132-49-6

中文名称
——
中文别名
——
英文名称
β-(3,4-dihydroxyphenyl)propionamide
英文别名
3-(3,4-Dihydroxy-phenyl)-propionsaeure-amid;Dihydrocaffeic acid amide;3-(3,4-dihydroxyphenyl)propanamide
β-(3,4-dihydroxyphenyl)propionamide化学式
CAS
1132-49-6
化学式
C9H11NO3
mdl
——
分子量
181.191
InChiKey
ZADDTMULPKDHLI-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    140 °C
  • 沸点:
    493.4±35.0 °C(Predicted)
  • 密度:
    1.328±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    -1.2
  • 重原子数:
    13
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.22
  • 拓扑面积:
    83.6
  • 氢给体数:
    3
  • 氢受体数:
    3

反应信息

  • 作为产物:
    描述:
    3,4-二苄氧基苯甲醛 在 palladium on activated charcoal 哌啶氢气 作用下, 以 吡啶溶剂黄146 为溶剂, 生成 β-(3,4-dihydroxyphenyl)propionamide
    参考文献:
    名称:
    合成von Catechol-O-methyl-transferase-hemmenden Verbindungen。在地下理工学院。1.米特隆
    摘要:
    描述了具有式I所示的一般结构的一系列化合物的合成。这些化合物,特别是3,4- dihydroxyphenylacetamide(XVI),是有效的和无毒性的抑制剂在体内儿茶酚-O-甲基转移酶。它们与邻苯三酚和该酶的其他已知抑制剂相比具有优势。
    DOI:
    10.1002/hlca.19620450133
点击查看最新优质反应信息

文献信息

  • [EN] COMPOSITION AND METHODS FOR TETHERING BIOACTIVE PEPTIDES TO METAL OXIDE SURFACES<br/>[FR] COMPOSITION ET PROCÉDÉS DE FIXATION DE PEPTIDES BIOLOGIQUEMENT ACTIFS SUR DES SURFACES D'OXYDES MÉTALLIQUES
    申请人:BECKER MATTHEW
    公开号:WO2016007943A1
    公开(公告)日:2016-01-14
    In various aspects, embodiments of the present invention are directed to a series of multivalent dendrons containing a bioactive peptide domain and surface-binding catechol domains. In some embodiments, these multivalent dendrons were obtained through solid phase synthesis and have a strong binding affinity to metal oxide surfaces such as, TiO2, ZrO2, CeO2, and Fe3O4, SiO2, as well as other inorganic surfaces such as hydroxyapatite, silver, fluorapatite, calcium carbonate and gold. These catechol-bearing dendrons provide a fast and efficient method to functionalize a wide range of inorganic materials with bioactive peptides and have the potential to be used in coating orthopaedic implants and fixation devices.
    在各个方面,本发明的实施例涉及一系列包含生物活性肽结构域和表面结合儿茶酚结构域的多价树状分子。在某些实施例中,这些多价树状分子是通过固相合成获得的,并且对金属氧化物表面(如TiO2、ZrO2、CeO2和Fe3O4、SiO2)以及其他无机表面(如羟基磷灰石、银、氟磷灰石、碳酸钙和金)具有很强的结合亲和力。这些含有儿茶酚的树状分子提供了一种快速高效的方法,可以将生物活性肽功能化到各种无机材料上,并有潜力用于包覆骨科植入物和固定装置。
  • 3,4-dihydroxybenzyl-substituted carbonic acid derivatives and the use thereof as antioxidants
    申请人:——
    公开号:US20030139470A1
    公开(公告)日:2003-07-24
    The invention relates to 3,4-dihydroxybenzyl-substituted carbonic acid derivatives, to their production, and to their use as antioxidants or free-radical scavengers, especially in cosmetic and pharmaceutical preparations and in foodstuffs and stimulants, to protect cells and tissues from the harmful effects of radicals and reactive oxygen compounds that accelerate aging. The invention further relates to cosmetic and pharmaceutical preparations and to foodstuffs and stimulants that comprises the inventive 3,4-dihydroxybenzyl-substituted carbonic acid derivatives.
    本发明涉及3,4-二羟基苯甲基取代的碳酸衍生物,其制备方法以及它们在抗氧化剂或自由基清除剂中的应用,特别是在化妆品和制药制剂以及食品和兴奋剂中,以保护细胞和组织免受加速衰老的自由基和反应性氧化化合物的有害影响。本发明还涉及包含创新的3,4-二羟基苯甲基取代的碳酸衍生物的化妆品和制药制剂以及食品和兴奋剂。
  • 3,4-Dihydroxymandelic acid alkylamides and use thereof
    申请人:——
    公开号:US20030171617A1
    公开(公告)日:2003-09-11
    The invention relates to N-alkyl-2-(3,4-dihydroxyphenyl)-2-hydroxyacetamides and to cosmetic and/or pharmaceutical preparations and foods comprising these compounds.
    本发明涉及N-烷基-2-(3,4-二羟基苯基)-2-羟基乙酰胺以及含有这些化合物的化妆品和/或药物制剂和食品。
  • DIHYDROCAFFEIC ACID AMIDE DERIVATIVE AND APPLICATION THEREOF AS MEDICINE
    申请人:MITSUI TOATSU CHEMICALS, Inc.
    公开号:EP0495998A1
    公开(公告)日:1992-07-29
    A medicine for treating central nervous system diseases containing a dihydrocaffeic acid amide derivative represented by general formula (I), which has an activity of inducing a nerve growth factor and is efficacious in treating or preventing the progression of central nervous system diseases.
    一种治疗中枢神经系统疾病的药物,含有通式(I)代表的二氢咖啡酸酰胺衍生物,该衍生物具有诱导神经生长因子的活性,可有效治疗或预防中枢神经系统疾病的恶化。
  • Solubilizer for cosmetic preparations
    申请人:Symrise AG
    公开号:US10758468B2
    公开(公告)日:2020-09-01
    The present invention relates to a mixture comprising (i) one or a plurality of 1,2-alkane diols with 5 through 8 carbon atoms and (ii) one or a plurality of ammonium-, sodium- or potassium-Ralk-sarcosinates, wherein the structural element Ralk represents alkanoyl, alkenoyl or alkadienoyl with 12 through 22 carbon atoms, and optionally (iii) one or a plurality of sodium- or potassium-C10-C16-alkyl-sulfoacetates. The invention further relates to particular compositions and cosmetic preparations, in particular body care products, containing said mixture or composition and methods of production thereof. The present invention further relates to the use of said mixture as solubilizer and for increasing the transparency or decreasing the turbidity of a preparation containing one or a plurality of further organic substances.
    本发明涉及一种混合物,该混合物包含(i)一种或多种具有 5 至 8 个碳原子的 1,2-烷 二醇;(ii)一种或多种铵、钠或钾-Ralk-肌氨酸盐,其中结构元素 Ralk 代表具有 12 至 22 个碳原子的烷酰基、烯酰基或烷二烯酰基;以及(iii)一种或多种 C10-C16 烷基磺基乙酸酯钠或钾。本发明还涉及含有上述混合物或组合物的特定组合物和化妆品制剂,特别是身体护理产品及其生产方法。本发明还涉及将所述混合物用作增溶剂,以及用于增加含有一种或多种其他有机物质的制剂的透明度或降低其浑浊度。
查看更多